All the news Showing 10 of 819 articles from: Health services, policy and advocacyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Few countries will meet 2020 target for reducing viral hepatitis deaths Keith Alcorn / 24 November 2020 Around 1.1 million deaths were caused by viral hepatitis worldwide in 2019 and deaths due to hepatitis C are still rising despite the availability of direct-acting antiviral treatment, according to analyses of ... Can investment in hepatitis C treatment be cost saving? Keith Alcorn / 24 November 2020 Direct-acting antiviral treatment for hepatitis C can be cost saving for some countries within five to ten years, especially if they can negotiate lower drug prices, a study presented online at this ... State Policies Create Barriers to Hepatitis C Elimination Hep Mag / 17 November 2020 Minimal monitoring of hepatitis C treatment is safe and effective Keith Alcorn / 17 November 2020 Hepatitis C treatment with no monitoring visits during treatment is safe and leads to a high cure rate, an international study reported on Monday at the online AASLD Liver Meeting. The study was ... Hepatitis C eradication in Korea 10 years behind WHO target Korea Biomedical News / 13 October 2020 Over 10 million patients, India’s 10-year Hepatitis C elimination deadline seems far Indian Express / 13 October 2020 Test and treat reduces hepatitis C by 83% in Melbourne gay men with HIV Keith Alcorn / 13 October 2020 Testing and treatment for hepatitis C in gay and bisexual men with HIV in Melbourne reduced the prevalence of the infection by 83% between 2012 and 2019, Australian researchers report ... Many People on Medicaid and Prisoners Still Lack Access to Hepatitis C Treatment Hep Mag / 28 September 2020 Only one in four high-income countries on track for hepatitis C elimination by 2030 Keith Alcorn / 28 August 2020 Only one in four high-income countries is on track to eliminate hepatitis C by 2030 and nearly two-thirds will miss the targets by more than 20 years at current rates of progress, ... COVID-19 leads to challenges ‘at every single step’ of HCV care cascade Healio / 18 August 2020 ← Prev1...34567...82Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive